Head-to-head · Value Score
Trimi Health vs Wellorithm
Two GLP-1 deals, scored on the same six factors. Trimi Health lands a Value Score of 89, Wellorithm a 51. Here's who gives you the honest lower price — and where each one bites back.
Trimi Health
#3 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameWellorithm
#42 · Grade C · Watch List
Est. first month
Pricing not published
The verdict
Trimi Health takes it on Value Score, 89 to 51 — an est. $99/mo first month, with no teaser step-up baked in. Wellorithm isn't out of it: People who specifically want an oral dissolving tablet alongside brand-name pens and will complete an intake quiz before learning what any of it costs.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Trimi Health | Wellorithm |
|---|---|---|
| Value Score | 89 (A) | 51 (C) |
| Est. first month | $99/mo | Pricing not published |
| Save vs brand-name | ~93% | — |
| Semaglutide | $99/mo | Pricing not published |
| Tirzepatide | $125/mo | Pricing not published |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 49 states (not Louisiana) |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Trimi Health
The ultra-budget pick: two-digit semaglutide and a $125 tirzepatide — one of the lowest flat tirz stickers on the whole board — shipped to all 50 states.
Why it's a deal
- Ultra-budget on both molecules — $99 semaglutide and a class-low $125 tirzepatide, flat with no teaser step-up
- Tirzepatide at $125/mo undercuts most of the flat-fee field on the priciest molecule
- Nationwide 50-state reach, so the low price isn't gated to a handful of states
The fine print
- Not LegitScript-certified — do your own pharmacy diligence before you buy on price alone
- Compounded injectable only — no FDA-approved brand-name or oral/sublingual route
- Newer brand with a thin public track record
Wellorithm
Four compounded routes plus four branded pens — and not one price anywhere on the public site.
Why it's a deal
- Both molecules in BOTH routes — compounded semaglutide and tirzepatide as injections and as oral dissolving tablets
- Four branded pens on the same account: Mounjaro, Ozempic, Wegovy and Zepbound
- Sermorelin offered alongside the GLP-1 line
- Serves 49 states, so most of the country is covered
The fine print
- No price appears anywhere on the public site — /pricing returns 404 and every product CTA leads to an intake quiz, so no cost can be compared before signing up
- The site contradicts itself on coverage: the homepage says "Serving All 50 States" while its own FAQ says it is available in 49 states and cannot provide services in Louisiana
- The four clinicians presented as "board-certified obesity specialists" are listed as Cardiac Surgery, Pediatric Clinic, Gynecology and Cardiac Surgery — none in obesity medicine
- "100% Customer Satisfaction" is stated as a headline fact and is not a substantiable claim
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.